News

Press ReleaseCGT Catapult and Nakanoshima Qross to foster stronger relationships between the advanced therapies industry in the UK and Japan
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2025202420232022 →
Challenge Theme R&D spotlight: CGT Catapult HEK cell line developed to optimise rAAV vector productionChallenge Theme R&D spotlight: CGT Catapult HEK cell line developed to optimise rAAV vector productionRegulatory Round-up - April 2025Regulatory Round-up - April 2025INmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readinessINmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readinessRegulatory Round-up - March 2025Regulatory Round-up - March 2025Regulatory Round-up - February 2025Regulatory Round-up - February 2025Network established to identify opportunities for regulation to support innovation within advanced therapiesNetwork established to identify opportunities for regulation to support innovation within advanced therapiesRegulatory Round-up - January 2025Regulatory Round-up - January 202570% increase in Phase I advanced therapy clinical trials in the UK in 202470% increase in Phase I advanced therapy clinical trials in the UK in 2024Regulatory Round-up - December 2024Regulatory Round-up - December 2024Cell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturingCell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturingRegulatory Round-up - November 2024Regulatory Round-up - November 2024Cell and gene therapy industry continues to expand manufacturing infrastructure in the UKCell and gene therapy industry continues to expand manufacturing infrastructure in the UK